Price range: $74.00 through $222.00 / 10 Vials
HGH 191AA (Somatropin) is a high-purity, recombinant human growth hormone produced via E. coli recombinant DNA technology. It is identical in structure and function to the growth hormone naturally secreted by the human pituitary gland. It is the gold standard in research for systemic tissue regeneration, muscle growth, fat metabolism, and significant anti-aging effects.
Amino Acid Sequence
A single chain of 191 amino acid residues (The sequence is identical to natural human growth hormone produced by the pituitary gland).
Molecular Formula
$C_{990}H_{1529}N_{263}O_{299}S_{7}$
Molecular Weight
22,125 g/mol (22.1 kDa)
PubChem CID
57026131
CAS Number
12629-01-5
Vial Size
3ml or 5ml (Commonly sold as 10 IU, 12 IU, or 36 IU per vial)
Contents
Lyophilized powder, white color (Typically high-purity freeze-dried cake)
| Size | 36iu, 24iu, 12iu, 10iu |
|---|---|
| Mechanism of Action | Direct Growth Stimulation: Binds to the Growth Hormone Receptor (GHR) on target cells, activating the JAK2/STAT5 signaling pathway to promote cell division and growth. IGF-1 Induction: Primarily acts on the liver to stimulate the synthesis and release of Insulin-like Growth Factor 1 (IGF-1), which mediates most of the growth-promoting effects on bone and muscle. Lipolysis & Metabolic Shift: Directly promotes the breakdown of stored triglycerides in adipocytes (fat cells) and shifts the body's energy source from glucose to fatty acids. Tissue Repair & Anti-Aging: Enhances protein synthesis and mineral retention, leading to improved skin elasticity, faster injury recovery, and increased bone density. |
| Storage & handling | Storage:Store the lyophilized vial in a cool, dry area protected from direct sunlight. |
All products on this site are for laboratory research, development, or analytical use only; they are NOT FOR HUMAN CONSUMPTION, medical, diagnostic, cosmetic, or veterinary applications.
These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat, or prevent any disease. Genixpep is not a compounding or outsourcing facility under sections 503A/503B of the FD&C Act.
